{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[13,2,13,3],[14,2,14,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910165027303321"]
[null,null,"Autore",null,"Waller Patrick <1957 January 30->"]
[null,null,"Titolo",null,"An introduction to pharmacovigilance / / Patrick Waller, Mira Harrison-Woolrych"]
[null,null,"Pubbl/distr/stampa",null,"Chichester, West Sussex, UK ; ; Hoboken, NJ : , : John Wiley & Sons Incorporated, , 2017"]
[null,null,"ISBN",null,"1-119-28978-5"]
[{"$nulls":4},"1-119-28975-0"]
[{"$nulls":4},"1-119-28977-7"]
[null,null,"Edizione",null,"[Second edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (193 pages) : illustrations"]
[null,null,"Collana",null,"THEi Wiley ebooks"]
[null,null,"Disciplina",null,"615/.7042"]
[null,null,"Soggetti",null,"Drug monitoring"]
[{"$nulls":4},"Drugs - Side effects"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"What is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Clinical aspects of adverse drug reactions -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance."]